跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 86 条关于
“C.diff”
全部
86
临床试验
39
药物
5
机构
6
资讯
36
去年
New Study Raises Safety Concerns About Fecal Microbiota Transplants
去年
Cardiff Oncology's Onvansertib Shows Promise in Metastatic Castration-Resistant Prostate Cancer
去年
Cardiff Oncology's Onvansertib Shows Promising Results in RAS-Mutated Metastatic Colorectal Cancer Trial
去年
Cardiff Oncology Secures Second Patent for Onvansertib in Bevacizumab-Naïve mCRC Patients
2年前
FDA Commissioner Defends Approval Standards Amidst Trial Failures
2年前
Cardiff Oncology's Onvansertib Enters Phase 2 Trial for KRAS/NRAS-Mutated Metastatic Colorectal Cancer
去年
New Alzheimer's Resource Center Opens in Dallas, Expanding Access to Treatment and Research
3年前
Pharma Industry Braces for $200B Patent Cliff as Biologics Face Biosimilar Competition
9个月前
Pharmaceutical M&A Activity Surges as Companies Brace for 2026 Patent Cliff
去年
Merck Faces Strategic Challenges as $29.5B Keytruda Patent Cliff Approaches in 2028
第 1 页,共 4 页
上一页
下一页